Strict construction of exemption notifications governed intravenous fluids with medicaments; earlier unrestricted relief applied, later restricted coverage did not.

Exemption for intravenous fluids depended on the wording of the relevant notifications. The earlier notifications under Notification No. 6/2000-C.E. read with Notification No. 36/2000-C.E. were unrestricted, so fluids mixed with medicines and drugs remained eligible up to 28-2-2001. From 1-3-2001, Notification No. 3/2001-C.E. confined the exemption to intravenous fluids used for sugar, electrolyte or fluid replenishment, and that restricted language could not be expanded to cover therapeutic medicaments. In a remand proceeding, additional evidence could not be introduced beyond the limited scope fixed by the remand order, and the request was dismissed. Penalty was not sustainable because the dispute turned on interpretation of exemption notifications, so the penalties were set aside.

---

---

Issues: (i) whether the assessees could be permitted to lead additional evidence beyond the limited scope of remand; (ii) whether intravenous fluids mixed with medicines and drugs were entitled to exemption under Notification No. 6/2000-C.E. read with Notification No. 36/2000-C.E. for the period up to 28-2-2001 and under Notification No. 3/2001-C.E. from 1-3-2001 onwards; (iii) whether penalty could be sustained.

Issue (i): whether the assessees could be permitted to lead additional evidence beyond the limited scope of remand

Analysis: The remand was confined to the issues specifically indicated by the Supreme Court. The liberty to adduce evidence was limited to the question relating to the warning regarding Schedule H drug, and the assessees sought to introduce material that went beyond that subject. In a remand proceeding, the Tribunal is bound by the scope of the remand order, and additional evidence cannot be allowed as of right. The applications did not disclose sufficient cause for non-production before the original authority.

Conclusion: The applications for additional evidence were not maintainable and were dismissed.

Issue (ii): whether intravenous fluids mixed with medicines and drugs were entitled to exemption under Notification No. 6/2000-C.E. read with Notification No. 36/2000-C.E. for the period up to 28-2-2001 and under Notification No. 3/2001-C.E. from 1-3-2001 onwards

Analysis: The earlier notifications granted exemption to intravenous fluids without qualification. Notification No. 3/2001-C.E. introduced a restricted description confined to intravenous fluids used for sugar, electrolyte or fluid replenishment. The explanatory note in the 2001-2002 Budget did not give retrospective effect to the restriction. Applying the language of the notifications strictly, and keeping in view the burden on the assessee, fluids containing therapeutic medicines and drugs could not be brought within the restricted notification from 1-3-2001 onwards. For the earlier period, the unrestricted notifications continued to apply and their benefit could not be denied merely because the fluids contained added medicaments.

Conclusion: The assessees were entitled to exemption for the period up to 28-2-2001, but not entitled to exemption under Notification No. 3/2001-C.E. from 1-3-2001 onwards.

Issue (iii): whether penalty could be sustained

Analysis: The dispute turned on interpretation of exemption notifications and the extent of their coverage. In such a case, penalty was not justified.

Conclusion: The penalties were set aside.

Final Conclusion: The orders were sustained only to the extent of denial of exemption for the period from 1-3-2001 onwards, while the benefit of the earlier exemption notifications was allowed and the penalties were quashed.

Ratio Decidendi: Where an exemption notification is expressed in restricted terms, its coverage must be determined strictly from its language and cannot be enlarged by implication, while an earlier unrestricted exemption cannot be denied retrospectively in the absence of clear legislative intent.

---